Mind the gap

With increased public funding in coronavirus detection and vaccines, and restrictions on funding from the EU, will there be a major gap in life science funding?


RICHARD HEBDON | Interim Deputy Director – Health & Life Sciences | Innovate UK


CLAIRE BROWN | Investment Director | BioCity
PHIL L’HUILLIER | Chief Executive Officer | CatalYm
REBECCA TODD | Investment Director | Longwall Venture Partners
JOE DE SOUSA | Senior Leader, Non-Exec Director and Independent Consultant | Melhor Consulting
DEBORA LUCARELLI | Chief Executive Officer | Enhanc3D Genomics